Detalhe da pesquisa
1.
Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression: the ASSURE study.
Psychol Med
; 53(10): 4811-4819, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803587
2.
Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM.
Psychol Med
; 53(10): 4831, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078398